Compass will share select off-MLS listings with Redfin under a new three-year agreement that could alter how some properties are marketed.

This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets.

Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...

Rocket Pro adds Pro Purchase Power, offering 40 bps more with Compass buyer agents, and launches Jupiter loan origination system.

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced that tomorrow it will report new clinical data from two ...

Learn how to find the current needed to deflect a compass needle in this step-by-step physics tutorial! Explore the principles of magnetic fields, current-carrying wires, and the interaction with a ...

Evidence of durability of psilocybin-based COMP360 is a key point for the FDA, according to Compass Pathways Chief Medical ...

LONDON & NEW YORK, February 16, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced ...

The Brookfield-owned hyperscale developer is planning to issue asset-backed securities backed by six new, fully leased data centers in Phoenix and Toronto, according to a presale report from Moody’s ...

Investing.com - Canaccord Genuity raised its price target on Compass Therapeutics (NASDAQ:CMPX) to $13.00 from $10.00 on Wednesday, while maintaining a Buy rating on the stock. The new target ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Compass Group PLC CPG shares rallied 2.79% to £22.48 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 1.15% to 10,341.56.